VASVX | VMVAX | VASVX / VMVAX | |
Total Expense Ratio | 0.42 | 0.07 | 600% |
Annual Report Gross Expense Ratio | 0.42 | 0.07 | 600% |
Fund Existence | 29 years | 14 years | - |
Gain YTD | -1.774 | -0.775 | 229% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 3000 | 3000 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 5.96B | 29.1B | 20% |
Annual Yield % from dividends | 1.84 | 2.40 | 77% |
Returns for 1 year | -11.52 | 4.10 | -281% |
Returns for 3 years | -7.26 | 15.69 | -46% |
Returns for 5 years | 36.73 | 77.99 | 47% |
Returns for 10 years | -10.82 | 74.68 | -14% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FNGG | 176.49 | 1.57 | +0.90% |
Direxion Daily NYSE FANG+ Bull 2X Shares | |||
FVAL | 60.95 | N/A | N/A |
Fidelity Value Factor ETF | |||
MMCA | 21.04 | N/A | N/A |
NYLI MacKay California Muni Intmdt ETF | |||
SPEM | 41.47 | -0.12 | -0.29% |
SPDR® Portfolio Emerging Markets ETF | |||
QMOM | 60.50 | -0.28 | -0.46% |
Alpha Architect US Quantitative Momt ETF |